| 000 | 01126 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250514165909.0 | ||
| 264 | 0 | _c20040416 | |
| 008 | 200404s 0 0 eng d | ||
| 022 | _a1057-9230 | ||
| 024 | 7 |
_a10.1002/hec.825 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHeitjan, Daniel F | |
| 245 | 0 | 0 |
_aBayesian estimation of cost-effectiveness: an importance-sampling approach. _h[electronic resource] |
| 260 |
_bHealth economics _cFeb 2004 |
||
| 300 |
_a191-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aBayes Theorem |
| 650 | 0 | 4 |
_aClinical Trials as Topic _xeconomics |
| 650 | 0 | 4 |
_aCost-Benefit Analysis _xmethods |
| 650 | 0 | 4 |
_aHeart Diseases _xeconomics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aSample Size |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aLi, Huiling | |
| 773 | 0 |
_tHealth economics _gvol. 13 _gno. 2 _gp. 191-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/hec.825 _zAvailable from publisher's website |
| 999 |
_c14463016 _d14463016 |
||